HERB CROSS
CIK 1230721 · Chief Financial Officer · last filed 2026-01-05
HERB CROSS is a Chief Financial Officer who has filed 48 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for JSPRW, was dated Jan 5, 2026. Across all open-market trades the lifetime net is −$513.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $123.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$123.6K
8
48
-$513.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JSPRW | Chief Financial Officer | — | $0.01 | — | $0 | 5 | 2026-01-05 |
| Atreca, Inc. (BCEL) Delisted | Chief Financial Officer | 72,817 | $0.15 | $10.9K | -$18.8K | 8 | 2023-08-04 |
| Apexigen, Inc. (APGNW) Delisted | Director | — | $0.03 | — | $0 | 1 | 2022-10-03 |
| ARMO BioSciences, Inc. (ARMO) Delisted | Chief Financial Officer | — | — | — | $0 | 1 | 2018-06-22 |
| HUMANIGEN, INC (KBIO) Delisted | Chief Financial Officer | — | — | — | $0 | 14 | 2015-11-10 |
| AFFYMAX INC (AFFY) Delisted | Chief Financial Officer | 21,370 | — | — | -$495.0K | 6 | 2013-02-01 |
| FACT | VP of Finance/Prin Acctg Off | 11,602 | $10.65 | $123.6K | $0 | 7 | 2010-04-21 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Corp Controller/Prin Acctg Off | 5,031 | — | — | $0 | 4 | 2008-09-17 |
Recent Filings
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2025-02-18 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2024-02-20 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2023-09-26 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2023-08-25 | — | Disp (D) | — | $0 | |
| 2023-08-04 | Atreca, Inc. (BCEL) Delisted | Sell (S) | −5,487 | -$5.2K | EDGAR |
| 2023-02-13 | Atreca, Inc. (BCEL) Delisted | Grant (A) | +43,750 | $0 | EDGAR |
| 2022-10-03 | Apexigen, Inc. (APGNW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-20 | Atreca, Inc. (BCEL) Delisted | Sell (S) | −7,646 | -$13.6K | EDGAR |